Yuuichi Arakawa
Takeda (Japan)(JP)
Publications by Year
Research Areas
Genetics and Neurodevelopmental Disorders, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Neurotransmitter Receptor Influence on Behavior, MicroRNA in disease regulation
Most-Cited Works
- → LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models(2021)37 cited
- → Transgenic mice overexpressing miR-137 in the brain show schizophrenia-associated behavioral deficits and transcriptome profiles(2019)26 cited
- → Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds(2013)13 cited
- → Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors(2014)7 cited
- → CCDC 895158: Experimental Crystal Structure Determination(2013)
- → CCDC 964884: Experimental Crystal Structure Determination(2014)